Eli Lilly & Co. (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. Its products span oncology, diabetes, immunology, neuroscience, and other therapies. The company is one ...

By Dr. Arshpreet Saraan Weight loss injectables have been making headlines in the papers and across social media the past couple of years, but how much do we really know about them?   Ozempic, Wegovy, ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

Note: The FDA has recently approved Zepbound ... cancer. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). To learn more, see the “Side effects explained ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech ... associated with a high degree of side effects, which Scorpion believes its ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...